The Serum Institute of India, more popularly known as SIU, is a global health research and development company that primarily produces vaccines for emerging diseases. Serum Institute Of India Share Price is Rs 278.15 per share. SIU is a renowned company operating in the Indian and global markets. The company is a subsidiary of NMC Health and the American pharmaceutical company Pfizer Inc. However, Pfizer does not own the company. Despite being a subsidiary of NMC Health and Pfizer Inc., Serum Institute Of India Share Price is considerably lower when compared to its peers.
Serum Institute Of India History
Serum Institute Of India History is the story about our company’s history that gives us a clear insight about the company’s operations through its various phases. The Serum Institute of India, also known as SIU, was established in 1974 by Dr. (Prof.) S.D. Bajpai, who was an eminent pioneer of the Indian pharmaceutical industry and a freedom fighter during the pre-independent era of India. He founded his own pharmaceutical firm called Research Farm Siasia . The institute began its research with Dr. Bajpai’s contribution in the 1970s and since then, it has become one of the best institutes for biological research in the country.
Facts About Serum Institute Of India :
Serum Institute Of India Facts is the story about the company’s journey from its very inception and till date. The Serum Institute was established in 1974 in Kolkata by Dr. (Prof.) S.D. Bajpai, an eminent pharmacist, who founded his own pharmaceutical firm called Research Farm Siasia in the 1970s. Serum Institute has been operative since its foundation and has never seen an interruption in its operations since then and it is one of the best institutes for biological research in the country.
Key Facts About Serum Institute Of India :
Serum Institute Of India Key Facts is the collection of facts which helps in understanding and researching the company. The Serum Institute of India, also known as SIU, is a research institute based in Kolkata that conducts biological research. Serum Corporation Limited (SCL) is a public sector enterprise under the Ministry of Health and Family Welfare and was established by an act of Parliament passed in 1972 as a Public Sector Undertaking (PSU) under the Indian Council for Medical Research (ICMR), to provide Medical Research Services. When NMC Health took over management control of Serum Corporation Ltd., SCL became an Affiliate unit under NMC Health. The firm has 1,955 employees(as of Dec. 31, 2012) and operates from four locations in Kolkata, Pune, Chennai and Noida.
Biological Research of Serum Institute Of India:
Serum Institute Of India Biological Research includes knowledge about the biological and physical aspects of a living organism. The company is known for its research on the diseases and diseases which have been transmitted via blood, blood products, breast milk etc. Serum Corporation Limited (SCL) is a subsidiary of NMC Health and American pharmaceutical giant Pfizer Inc., where it produces vaccines for emerging diseases. These vaccines are then supplied to various states to help control rather than eliminate diseases like bird flu etc.
Serum Institute Of India Products:
Serum Institute Of India Products is the company’s product portfolio. All the products produced by Serum Institute of India are of high quality and are well tested before being available for consumer consumption. In 2008, Serum Institute of India had produced 55 vaccines including: Filaria vaccine against filariasis and Serratia vaccine against trachoma and other eye diseases in addition to chicken pox vaccine, rotavirus vaccine and yellow fever vaccines. The company also produces doxycycline, a powerful antibiotic that is used to treat various bacterial infections.